AGORACOM News Flash

AGORACOM WIRE - WEDNESDAY MAY 30TH, 2012

GOLDEN HOPE MINES (TSXV:GNH) Confirms High Grade Intersection of 64.1 g/t Au (Gold) over 1m Read More

The screen metallic analysis returned 82 g/t Au for an average grade of 93.5 g/t Au.
Two additional fire assays on the original pulp done prior to the screen metallic analyses returned 0.22 g/t Au and 0.12 g/t Au for an average fire assay grade of 0.41 g/t Au. The weighted average of all the fire assays and screen metallic assays from this 1-metre section in hole BD2011-184 is 64.1 g/t Au.

Sonomax® eers™ Custom Earbuds Announces Sponsorship of MUTEK 2012

Mutek provides an essential platform for 150 performers to showcase forward-thinking electronic music programming and new media to more than 25,000 attendees
Read Full Press Release; Read Why Sonomax?
Jump Into Active Discussion Forum
*Sponsor*

CONTINENTAL ENERGY Geothermal Energy Project Receives US$ 11.5 Million Grant Read More * Client

AGORACOM Launches Graphite Stocks Blog

Message: NEWS -- Haemacure appoints new Chief Executive Officer

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

AGORACOM

Rank: [?]

President

Points: [?]

11204

Rating: [?]

Votes: 30 Score: 4.0

Currently 4.0/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

NEWS -- Haemacure appoints new Chief Executive Officer

posted on Feb 05, 07 11:41AM

Montreal, February 5, 2007 – Haemacure Corporation (TSX : HAE), a Montreal-based biotechnology company, announced today that Mr. Joseph Galli was appointed Chief Executive Officer of the corporation, effective February 1, 2007. Mr Galli is also Chairman of the Board of Haemacure and will hold both offices. Mr. Galli will be based in Montreal.

Mr. Marc Paquin will continue to hold the office of President and to serve as a director of Haemacure.

Mr. Galli enjoys more than 20 years of experience in financing, mergers and acquisitions and restructuring and will work closely with Mr. Paquin in developing and implementing Haemacure’s business development strategy.

Haemacure Corporation is a Canadian company in development stage and is specialized in the development of innovative biological adhesives, biomaterials and surgical devices for the acute surgical wound care market. It also operates offices in Sarasota, Florida through a wholly-owned subsidiary. The Corporation is traded under stock symbol HAE on the TSX.

For More Information:

Haemacure Corporation
Joseph Galli

Chairman and CEO

514-990-7074

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »